MedTrace Logo

Evaluation of the Role of Tramadol 50mg as an Analgesic During Outpatient Hysteroscopy

NCT02068209 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2015-04-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate the role of Tramadol 50mg in reducing pain during outpatient hysteroscopy.

Conditions

Interventions

DRUG

Tramadol

patients will receive Tramadol 50mg orally 1 hour before outpatient hysteroscopy.

DRUG

Placebo

patients will receive a placebo 1 hour before outpatient hysteroscopy

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • AbdelGany MA Hassan, MRCOG, MD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02068209 on ClinicalTrials.gov